Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. BioNTech - Wikipedia

   en.wikipedia.org/wiki/BioNTech

   Biontech FY 2023 report [ 1] BioNTech SE ( / biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[ 2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

3. Uğur Şahin - Wikipedia

   en.wikipedia.org/wiki/Uğur_Şahin

   Website. Profile at BioNTech. Signature. Uğur Şahin ( Turkish: [uˈuɾ ʃaː.hin]; born 19 September 1965 [ 3]) is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. [ 4][ 5] His main fields of research are cancer research and immunology.

4. Katalin Karikó - Wikipedia

   en.wikipedia.org/wiki/Katalin_Karikó

   University of Pennsylvania. BioNTech. Katalin " Kati " Karikó ( Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American [ 2] biochemist who specializes in ribonucleic acid ( RNA )-mediated mechanisms, particularly in vitro - transcribed messenger RNA (mRNA) for protein replacement therapy ...

5. BioNTech's cancer drug meets primary endpoint in Phase 2 trial

   www.aol.com/news/biontechs-cancer-drug-meets...

   (Reuters) - COVID-19 vaccine maker BioNTech's cancer drug candidate BNT111 showed significant improvement in the response rate in patients with advanced melanoma during a Phase 2 trial, the German ...

6. US FDA puts partial clinical hold on BioNTech's early-stage ...

   www.aol.com/news/us-fda-puts-partial-clinical...

   June 17, 2024 at 8:33 AM. (Reuters) - Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug Administration has placed a partial clinical hold on an early-stage study ...

7. BioNTech says FDA lifts partial hold on its cancer drug trial

   www.aol.com/news/biontech-says-fda-lifts-partial...

   August 19, 2024 at 3:59 AM. GDANSK (Reuters) - BioNTech on Monday said the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on an early stage study of its experimental ...